Literature DB >> 20174672

Therapeutic applications of hyaluronan.

John Gaffney1, Sabine Matou-Nasri, Marta Grau-Olivares, Mark Slevin.   

Abstract

Hyaluronan (HA), a multifunctional, high molecular weight glycosaminoglycan, is a component of the majority of extracellular matrices. HA is synthesised in a unique manner by a family of hyaluronan synthases, degraded by hyaluronidases and exerts a biological effect by binding to families of cellular receptors, the hyaladhedrins. Receptor binding activates signal pathways in endothelial cells leading to proliferation, migration and differentiation collectively termed angiogenesis. HA and associated enzymes are implicated in the aetiology of cardiovascular disease and cancer and manipulation of HA expression offers a therapeutic target. HA microspheres have been developed as drug delivery agents to deliver HA to sites of disease and also in diagnosis. In this review we discuss some of the recent therapeutic applications of hyaluronan in tissue repair, as a drug delivery system and the synthesis, application and delivery of hyaluronan nanoparticles to target drugs to sites of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20174672     DOI: 10.1039/b910552m

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  34 in total

Review 1.  Hyaluronan biology: A complex balancing act of structure, function, location and context.

Authors:  Stavros Garantziotis; Rashmin C Savani
Journal:  Matrix Biol       Date:  2019-02-23       Impact factor: 11.583

Review 2.  Endoglycosidases for the Synthesis of Polysaccharides and Glycoconjugates.

Authors:  Chao Li; Lai-Xi Wang
Journal:  Adv Carbohydr Chem Biochem       Date:  2016-08-23       Impact factor: 12.200

Review 3.  Hyaluronan fragments as mediators of inflammation in allergic pulmonary disease.

Authors:  Sumit Ghosh; Scott A Hoselton; Glenn P Dorsam; Jane M Schuh
Journal:  Immunobiology       Date:  2014-12-31       Impact factor: 3.144

Review 4.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

5.  Instillation of hyaluronan reverses acid instillation injury to the mammalian blood gas barrier.

Authors:  Ting Zhou; Zhihong Yu; Ming-Yuan Jian; Israr Ahmad; Carol Trempus; Brant M Wagener; Jean-Francois Pittet; Saurabh Aggarwal; Stavros Garantziotis; Weifeng Song; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-25       Impact factor: 5.464

6.  ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors.

Authors:  Nazmul H Bhuiyan; Michelle L Varney; Deep S Bhattacharya; William M Payne; Aaron M Mohs; Sarah A Holstein; David F Wiemer
Journal:  Bioorg Med Chem Lett       Date:  2019-08-20       Impact factor: 2.823

7.  Symptomatic response to GERDOFF® in patients with gastro-esophageal reflux disease and poor response to alginates: an exploratory, post-market, open-label study.

Authors:  Valentina Boarino; Ivana Raguzzi; Margherita Marocchi; Alberto Merighi
Journal:  Turk J Gastroenterol       Date:  2020-06       Impact factor: 1.852

8.  Intra-articular injection of hyaluronic acid for the reduction in joint adhesion formation in a rabbit model of knee injury.

Authors:  Min Wang; Chao Liu; Wei Xiao
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-06-06       Impact factor: 4.342

Review 9.  Hyaluronic acid (Supartz®): a review of its use in osteoarthritis of the knee.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

Review 10.  Hyaluronan regulation of endothelial barrier function in cancer.

Authors:  Patrick A Singleton
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.